Drs Ursula A. Matulonis and Gini F. Fleming discuss the state of endometrial cancer, the role of immunotherapy, and priorities for research in this field.

In a live virtual event, Thomas C. Krivak, MD, reviewed the key studies of PARP inhibitor and bevacizumab maintenance in ...

In 2022, more than 13,000 people died from ovarian cancer, according to the CDC. A common blood test for ovarian cancer is more likely to fall short for Black and Native American women ...

Trop-2 is a glycoprotein involved in cellular signal transduction and is differentially overexpressed relative to normal tissue in a variety of human adenocarcinomas, including endometrioid ...

Ovarian torsion occurs when an ovary twists around the ligaments that hold it in place. This twisting can cut off blood flow to the ovary and fallopian tube, leading to symptoms such as nausea ...

Invasive lobular carcinoma (ILC) affects the lobules of the breast, which contain the glands that produce breast milk. It is a type of breast cancer, and the outlook can vary depending on multiple ...

Friday, Oct. 24, 2014. (AP Photo/Pablo Martinez Monsivais, File) Updated [hour]:[minute] [AMPM] [timezone], [monthFull] [day], [year] A common blood test may miss ovarian cancer in some Black and ...

Malignant WAT occurring in the ovary is exceptionally uncommon ... indicated a malignant tumor with necrotic areas suggestive of poorly differentiated carcinoma. The patient subsequently underwent a ...

Chair of Proteomics and Bioanalytics, School of Life Sciences, Technical University of Munich, 85354 Freising, Germany Chair of Proteomics and Bioanalytics, School of Life Sciences, Technical ...

Toon Van Gorp, MD, PhD, discussed findings from the MIRASOL trial and the potential of mirvetuximab to redefine treatment paradigms in ovarian cancer. Mirvetuximab soravtansine-gynx (Elahere) ...